drugset / Trial / NCT06836284
The Evira Study: Additional Support During Obesity Treatment
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to evaluate the effect of adding a digi-physical treatment tool as a complement to the local treatment with obesity medication in adolescents with obesity. The main question it aims to answer is: \- Can a combination of a digi-physical treatment tool and obesity medication improve treatment outcomes for patients with obesity compared to patients treated with obesity medications alone? This is a randomized controlled two-arm multicenter study where participants will be randomized to the intervention group (digi-physical treatment+medication) or control group (medication only). Participants will be followed for six months.
Timeline
- Start
- 2026-02-13
- Primary completion
- 2027-04-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Liraglutide | Peptide | — | — |
| Background | Semaglutide | Peptide | — | — |
Indications
No indication recorded.